<DOC>
	<DOCNO>NCT02053805</DOCNO>
	<brief_summary>This prospective diagnostic trial screen prostate cancer among men genetic predisposition .</brief_summary>
	<brief_title>Prostate Cancer Screening Among Men With High Risk Genetic Predisposition</brief_title>
	<detailed_description>This prospective diagnostic trial screen prostate cancer among men genetic predisposition . The target population male ( 40-70 year old ) carry BRCA1 and/or BRCA2 germ line mutation . They identify via Genetic counsel unit . All men sign informed consent undergo follow test : PSA , free total PSA , MRI prostate prostate biopsy . The primary endpoint estimate prevalence , stage grade prostate cancer population . Additionally , study aim estimate impact germ line mutation benign prostatic hyperplasia . Furthermore , study aim create bio-bank tissue , urine serum unique cohort future investigation . Finally , study identify inception cohort future interventional study primary secondary prevention .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Disease Susceptibility</mesh_term>
	<mesh_term>Colorectal Neoplasms , Hereditary Nonpolyposis</mesh_term>
	<mesh_term>Genetic Predisposition Disease</mesh_term>
	<criteria>Male carrier mutation BRCA 1\2 germline mutation MMR gene ( MLH1 , MSH2 , MSH6 PMS2 ) . WHO performance status 02 ( Appendix 2 ) Absence psychological , familial , sociological geographical situation potentially hamper compliance study protocol followup schedule . Individuals undergo MRI exam due high creatinine level claustrophobic disc loud MRI part . Informed write consent must seek accord ICH/EU GCP , subject registration . Previous cancer terminal prognosis less five year . Previous prostate cancer</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>BRCA1 Syndrome</keyword>
	<keyword>BRCA germ-line mutation</keyword>
	<keyword>Lynch syndrome</keyword>
	<keyword>BRCA2 Syndrome</keyword>
</DOC>